An in-depth look to BORA PHARMACEUTICALS CO LTD operating, investing, and financing activities

6472 free cash flow for Q3 24 is 1.77 B TWD. For 2023, 6472 free cash flow was 4.16 B TWD and operating cash flow was 4.46 B TWD.